---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-000557"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2022-01-06T23:59:59+00:00"
generated_at: "2026-06-27T20:23:10.825252+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints Zachary Fleming as CEO effective Jan 1, 2022; grants 10,000 RSUs

## Summary
- Board appointed Zachary B. Fleming as CEO, effective January 1, 2022.
- Granted one-time restricted stock award of 10,000 shares of common stock.
- Shares vest in three equal installments on Jan 1, 2023, 2024, and 2025.

## SEC filing metadata
- accession: 0001493152-22-000557
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2022-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315222000557/0001493152-22-000557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315222000557/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-000557
- JSON: https://secwatch.observer/filing/0001493152-22-000557.json
- Plain text: https://secwatch.observer/filing/0001493152-22-000557.txt

## Key facts
- Executive change
  Zachary B. Fleming was appointed as Chief Executive Officer at Sanara MedTech Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315222000557/0001493152-22-000557-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.